4Alfredo Enguix,Corsino Rey,Andrés Concha,Alberto Medina,Daniel Coto,María Angeles Diéguez. Comparison of procalcitonin with C-reactive protein and serum amyloid for the early diagnosis of bacterial sepsis in critically ill neonates and children[J] 2001,Intensive Care Medicine(1):211～215
二级参考文献29
1史玉泉.实用神经病学，第2版[M].上海:上海科学技术出版社,1994.564-572.
2Snider RH Jr, Nylen ES, Becket KL. Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization[J]. J Investig Med, 1997,45(9) :552-560.
3Muller B, White JC, Nylen ES, et al. Ubiquitous expression of the caleitonink-1 gene in multiple tissues in response to sepsis[J]. J Clin Endocrinol Metab, 2001,86( 1 ) :396-404.
4Oberhoffer M, Stonans I, Russwt, rm S, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitra[J]. J Lab Clin Med, 1999.134(1 ) :49-55.
5Whang KT, Vath SD,Becker KL, et al.Procalcitoin and proinflammatory cytokine interactions in sepsis[ J].Shock, 2000,14(1 ) :73-78.
6Nylen ES, Whang KT, Snider RH Jr, et al. Mortality is increased byprocalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis[ J]. Crit Care Med, 1998,26 (6) : 1001-1006.
7Martinez JM, Becket KL, Mailer B, et al. Improved physiologic and metabolic parameters and increased survival with late procaleiton in immunoneutralization in septic pigs. In : 41 st Interscience Conference on Antimicrehiol Agents and Chemotherapy (ICAAC). Chicago, IL,2001.
8Brunkhorst FM, Heins U, Forycki ZF. Kinetics of pmcalcitonin in iatrogenic sepsis[ J]. Intensive Care Med, 1998,24(8) :888-889.
9Schroder J, Staubach KH, Zabel P, et al. Procalcitonin as a marker of severity in septic shock[J]. Langenbecks Arch Sum. 384( 1 ) :33-38.
10Marchini G, Berggren V, Djilalik-Merzoug R, et al. The birth process initiates an acute phase reaction in the fetus-newbom infant[J]. Aeta Paediatr, 2000, 89(9):1082-1086.
3Rimola A, Garcia-Tsao G, Navasa M, et al. Diagnosis, treatment and prophylaxis of spontaneous bacterial peri- tonitis:a consensus document. International Ascites Club [J]. J Hepatol,2000,32(1): 142-153.
4Ferndndez J, Bauer TM, Navasa M, et al. Diagnosis, treat- ment and prevention of spontaneous bacterial peritonitis [J]. Best Pract Res Clin Gastroenterol, 2000,14 (6) : 975- 990.
5Strauss E, Caly WR. Spontaneous bacterial peritonitis: a therapeutic update [J]. Expert Rev Anti Infect Ther, 2006,4(2) :249-260.
6Runyon BA, aasld Practice Guidelines Committee. Man- agement of adult patients with ascites due to cirrhosis:an update[J]. Hepatology, 2009,49 :2087-2107.
7European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syn- drome in clrrhosis[J]. J Hepatol, 2010,53 (3) : 397-417.
8Wiest R, Garcia-Tsao G. Bacterial tyanslocation (BT) in cirrhosis[J]. Hepatology, 2005,41 : 422-433.
9De Haas M. IgG-Fc receptors and the clinical relevance of their polymorphisms [J]. Wien Klin Wochenschr, 2001, 113(20/21) :825-831.
10Allen E, Bakke AC, Purtzer MZ, et al. Neutrophil CD64 expression: distinguishing acute inflammatory autoim- mune disease from systemic infections [J]. Ann Rheum Dis,2002,61(6) :522-525.
